New Key Statistics Module, Z-Score and F-Score
NAS:RPRX Key Ratios
Market Cap $ M | 12,888.26 |
Enterprise Value $ M | 17,829.49 |
P/E(ttm) | 19.17 |
PE Ratio without NRI | 26.22 |
Forward PE Ratio | 7.30 |
Price/Book | 1.99 |
Price/Sales | 7.64 |
Price/Free Cash Flow | 6.41 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.75 |
Revenue (TTM) $ M | 2,237.00 |
EPS (TTM) $ | 1.50 |
Beneish M-Score | -3.37 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -23.00 |
y-y EBITDA Growth Rate % | 174.30 |
EV-to-EBIT | 14.66 |
EV-to-EBITDA | 14.66 |
PEG | -- |
Shares Outstanding M | 448.13 |
Net Margin (%) | 30.09 |
Operating Margin % | 42.91 |
Pre-tax Margin (%) | 46.02 |
Quick Ratio | 9.35 |
Current Ratio | 9.35 |
ROA % (ttm) | 4.05 |
ROE % (ttm) | 10.54 |
ROIC % (ttm) | 6.47 |
Dividend Yield % | 2.89 |
Altman Z-Score | 1.67 |
RPRX Number of Guru Trades
RPRX Volume of Guru Trades
Gurus Latest Trades with NAS:RPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RPRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Royalty Pharma PLC Insider Transactions
No Available Data
News about NAS:RPRX
Total 0- 1